Jefferies Group LLC Pacira Bio Sciences, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 29,954 shares of PCRX stock, worth $568,526. This represents 0.02% of its overall portfolio holdings.

Number of Shares

29,954

Previous 7,500 299.39%

Holding current value

$568,526

Previous $437,000 264.53%

% of portfolio

0.02%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	BUY	$51.24 - $58.89 $1.15 Million - $1.32 Million	22,454 Added 299.39%	29,954 $1.59 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $1.2 Million - $1.38 Million	23,458 Added 312.77%	30,958 $1.59 Million
Q2 2022 Sep 21, 2023	SELL	$51.49 - $81.64 $1.09 Million - $1.74 Million	-21,255 Reduced 73.92%	7,500 $437,000
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $386,175 - $612,300	7,500 New	7,500 $437,000
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $1.38 Million - $1.79 Million	-28,755 Closed	0 $0
Q3 2021 Sep 21, 2023	BUY	$54.64 - $61.3 $970,133 - $1.09 Million	17,755 Added 161.41%	28,755 $1.61 Million
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $1.57 Million - $1.76 Million	28,755 New	28,755 $1.61 Million
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $650,980 - $769,890	-11,000 Closed	0 $0
Q1 2021 Sep 21, 2023	SELL	$59.31 - $78.82 $509,235 - $676,748	-8,586 Reduced 43.84%	11,000 $770,000
Q1 2021 May 14, 2021	SELL	$59.31 - $78.82 $509,235 - $676,748	-8,586 Reduced 43.84%	11,000 $771,000
Q4 2020 Sep 21, 2023	SELL	$50.47 - $66.26 $573,944 - $753,508	-11,372 Reduced 36.73%	19,586 $1.17 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $330,578 - $434,003	6,550 Added 50.25%	19,586 $1.17 Million
Q3 2020 Nov 13, 2020	BUY	$51.97 - $63.0 $313,690 - $380,268	6,036 Added 86.23%	13,036 $784,000
Q2 2020 Aug 14, 2020	SELL	$30.8 - $52.47 $5.8 Million - $9.88 Million	-188,393 Reduced 96.42%	7,000 $367,000
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $5.55 Million - $9.91 Million	195,393 New	195,393 $6.55 Million
Q4 2019 Feb 13, 2020	SELL	$36.31 - $46.83 $1,270 - $1,639	-35 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$35.66 - $44.99 $1.34 Million - $1.69 Million	-37,500 Reduced 99.91%	35 $1,000
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $513,954 - $674,170	14,054 Added 59.85%	37,535 $1.63 Million
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $293,364 - $339,215	8,044 Added 52.11%	23,481 $894,000
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $244,513 - $308,735	-5,919 Reduced 27.72%	15,437 $664,000
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $589,986 - $933,920	17,960 Added 528.86%	21,356 $1.05 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $93,390 - $135,160	3,396 New	3,396 $109,000
Q1 2018 May 15, 2018	SELL	$29.98 - $46.35 $308,883 - $477,544	-10,303 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $93,607 - $137,986	-2,939 Reduced 22.19%	10,303 $470,000
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $472,739 - $523,059	13,242	13,242 $497,000

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Pacira Bio Sciences, Inc. Transaction History